Clean Science and Technology (CLEAN) Q3 24/25 earnings summary

Executive summary

• Q3 FY25 delivered robust year-over-year revenue and profit growth, with all major product lines commercialized and global distribution networks expanding.

• New products DHDT and BHT were commercialized, and HALS segment saw continued volume scale-up and diversification.

• Interim dividend of ₹2 per share (200% of face value) was declared for FY 2024-25.

• Additional investment of ₹300 crore approved in Clean Fino-Chem Limited, supporting expansion.

Financial highlights

• Q3 FY25 consolidated revenue rose 23% YoY to ₹2,408.16 million, with consolidated EBITDA up 14% YoY to ₹985 million and margin at 41.5%.

• Q3 FY25 consolidated PAT was ₹656.43 million, up 5% YoY; standalone PAT was ₹741.09 million, up 10% YoY.

• 9M FY25 consolidated revenue was ₹7,029.61 million, with net profit at ₹1,903.13 million.

• Standalone EBITDA margin improved to 44.8% in Q3 FY25.

• Earnings per share (consolidated) for Q3 FY25 was ₹6.18, up from ₹5.89 in Q3 FY24.

Outlook and guidance

• Targeting 3,000–4,000 tons of HALS sales in FY26, with advanced products expected to improve realizations to $5.5–$6/kg.

• Major revenue growth expected from recently commercialized HALS and pharma intermediates, with global distribution networks established.

• Capex of ₹150 crore planned for water treatment chemicals and performance chemical plant commercialization by H2FY26.

• Strategic investments in R&D, greenfield capex, and sustainability initiatives to drive long-term growth.